Eradicate Cancer 2018
With immunotherapy having unprecedented successes in the clinic and rapidly emerging as the core medical platform for the treatment of cancer, an inaugural Eradicate Cancer conference will be held in Melbourne 15-17 March 2018. The conference title deliberately poses a provocative question and call to action: Eradicate Cancer 2018 - can advanced immunotherapy make it possible?
The conference will embrace the latest technologies and
clinical advances, including ‘supercharging’ a patient’s immune system by
firstly genetic engineering, empowering T cells with a cancer tracking ’GPS’
creating ‘cancer smart’ killer T cells, and secondly the removal of natural
‘hand brakes’ on immune responses, so they are better able to respond to
cancers. These so-called Chimeric Antigen Receptor T cells (CAR-T) and
checkpoint blockade inhibitors, respectively, are the pillars to this
immuno-oncology revolution. Fundamental to this is the management of treatment
related adverse events and the establishment of safe, effective and practical
methods for gene editing lymphocytes. It will also evaluate current strategies
to rejuvenate and reconstruct the immune system of cancer patients, given the
common immunodeficiency they present, as a result of chemotherapy and even
natural aging.
We look forward to welcoming you to the meeting! Those interested or involved in the field are encouraged to register their interest.